Current Health Expenditure in Argentina has shown fluctuations over the past decade. Actual values ranged from 9% to 10.44% of GDP between 2013 and 2023. Notably, spending peaked in 2017 at 10.44% and bottomed out in 2016 at 9%. The series saw an uptick post-2020, with 2023 standing at 10.13%. The five-year average annual growth rate (CAGR) from 2018 to 2023 was 1.29%. Year-on-year variations fluctuated widely, but the last two years saw consistent minor increases.
Forecasted data projects a gradual increase in health expenditure, reaching 10.54% of GDP by 2028. The five-year forward CAGR is 0.63%, indicating a steady yet slow upward trend.
Future trends to watch for include:
- Increased government funding in the healthcare sector.
- Impact of economic factors on public and private healthcare expenditure.
- Advancements in medical technology and their integration into healthcare services.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...